From Whitechapel to the world
Barts Life Sciences will deliver on three healthcare priorities – prevention, prediction and precision. To deliver on these priorities, we have four core areas of focus for translational research, through which we are already delivering world-leading results:
Precision-omics
Studying why different people get sick in different ways, so we can produce more personalised medicine tailored to individuals
Digital health
Using technology to help people monitor different conditions remotely, keeping them healthy, better able to track when they need support and become less reliant on hospitals
Population health
Studying the social, environmental and behavioural issues that may impact on how different conditions develop for different people, and finding better ways to prevent and treat them
Advanced medical technologies
Developing new materials to use in operations that will aid recovery and comfort
Precision-omics
Studying why different people get sick in different ways, so we can produce more personalised medicine tailored to individuals
Digital health
Using technology to help people monitor different conditions remotely, keeping them healthy, better able to track when they need support and become less reliant on hospitals
Population health
Studying the social, environmental and behavioural issues that may impact on how different conditions develop for different people, and finding better ways to prevent and treat them
Advanced medical technologies
Developing new materials to use in operations that will aid recovery and comfort
Today’s technology, tomorrow’s medicines
Cutting-edge technology, from AI technology to robotics and bio-engineering, will power our four core research pillars – digital health, precision-omics, advanced technologies and population health.
Technologies like AI play a vital role in allowing us to predict which medical conditions might affect people, how the condition might evolve over time and what treatments might prove most effective, and we believe we have the rich and diverse datasets that will unleash AI’s full potential in healthcare.
Through the London Local Health and Care Record Exemplar (LHCRE) initiative, we have already collated vast amounts of anonymised data from across primary, secondary and mental health sectors in East London. This initiative is helping us to embed digital change and enable service transformation on the ground, by making clinical information instantly available to teams delivering care to the population, allowing them to make more informed decisions.
We have deep experience in robotics and bio-engineering, with exciting new advancements including the creation of surgical robots that are capable of adapting to their environments better than their traditional rigid-body counterparts.
CAP-AI is a Barts Life Sciences pioneering research programme, aiming to place healthcare in East London at the forefront of the AI and technology revolution. CAP-AI will provide SMEs with access to clinicians, academics and high-quality data from London’s largest NHS Trust, as well as high-performing computational power and technical expertise and talent.